CAMBRIDGE, Mass., Sept. 7 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the Robert W. Baird Small Cap Healthcare Conference on Tuesday, September 14, 2010 at 9:30 a.m. ET at the St. Regis Hotel, New York City and at the Stifel Nicolaus Healthcare Conference on Thursday, September 16, 2010 at 11:30 a.m. ET at the Four Seasons Hotel, Boston.
The live and archived webcast of the company presentation can be accessed under “Calendar of Events” in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix’s current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com.
Idenix Pharmaceuticals Contact: | |
Jonae Barnes (617) 224-4485 (investors) | |
Kelly Barry (617) 995-9033 (media) | |
SOURCE Idenix Pharmaceuticals, Inc.
